22.93
price down icon4.29%   -1.065
 
loading
전일 마감가:
$24.00
열려 있는:
$23.86
하루 거래량:
16,935
Relative Volume:
0.08
시가총액:
$617.47M
수익:
-
순이익/손실:
$11.77M
주가수익비율:
-148.25
EPS:
-0.1547
순현금흐름:
$-19.23M
1주 성능:
-14.55%
1개월 성능:
-18.85%
6개월 성능:
+63.72%
1년 성능:
+30.59%
1일 변동 폭
Value
$22.81
$24.36
1주일 범위
Value
$22.81
$26.83
52주 변동 폭
Value
$12.12
$48.31

Tourmaline Bio Inc Stock (TRML) Company Profile

Name
명칭
Tourmaline Bio Inc
Name
전화
646-481-9832
Name
주소
27 WEST 24TH STREET, NEW YORK
Name
직원
74
Name
트위터
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
TRML's Discussions on Twitter

TRML을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
TRML 22.81 617.47M 0 11.77M -19.23M -0.1547
VRTX 447.00 115.74B 10.63B -479.80M -1.35B 13.33
REGN 742.11 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 588.93 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 249.68 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 103.55 24.49B 3.30B -501.07M 1.03B 11.54

Tourmaline Bio Inc Stock (TRML) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-12-15 개시 Jefferies Buy
2023-12-04 재개 H.C. Wainwright Buy
2023-11-17 개시 Truist Buy
2023-10-31 개시 Guggenheim Buy
2023-10-25 개시 Piper Sandler Overweight
2022-10-20 개시 H.C. Wainwright Buy
2022-07-05 다운그레이드 Morgan Stanley Overweight → Equal-Weight
모두보기

Tourmaline Bio Inc 주식(TRML)의 최신 뉴스

pulisher
Nov 18, 2024

Prevent Blindness Declares Fifth Annual Thyroid Eye Disease Awareness Week as Nov. 18-24, 2024 - InvisionMag

Nov 18, 2024
pulisher
Nov 17, 2024

This Week in Ophthalmology: Week of November 11, 2024 - Ophthalmology Times

Nov 17, 2024
pulisher
Nov 15, 2024

Blue Owl Capital Holdings LP Adjusts Stake in Tourmaline Bio Inc - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

HC Wainwright Reduces Earnings Estimates for Tourmaline Bio - Defense World

Nov 15, 2024
pulisher
Nov 14, 2024

HC Wainwright Lowers Earnings Estimates for Tourmaline Bio - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

Tourmaline Bio Sets Key Investor Day with Focus on Pacibekitug Development | TRML Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 14, 2024

Alternus Clean Energy Inc (NASDAQ:ALCE) Sees Significant Decrease in Short Interest - Defense World

Nov 14, 2024
pulisher
Nov 14, 2024

Alchemy Investments Acquisition Corp 1 (NASDAQ:ALCY) Short Interest Update - Defense World

Nov 14, 2024
pulisher
Nov 14, 2024

Short Interest in Alchemy Investments Acquisition Corp 1 (NASDAQ:ALCYW) Decreases By 97.6% - Defense World

Nov 14, 2024
pulisher
Nov 14, 2024

Tourmaline Bio (NASDAQ:TRML) Price Target Raised to $49.00 - Defense World

Nov 14, 2024
pulisher
Nov 14, 2024

Greenlane Renewables (OTCMKTS:GRNWF) Trading 21.2% Higher – Here’s What Happened - Defense World

Nov 14, 2024
pulisher
Nov 12, 2024

Tourmaline Bio ATM - SVB Leerink

Nov 12, 2024
pulisher
Nov 12, 2024

Varonis Systems, Inc. (NASDAQ:VRNS) Given Average Rating of “Moderate Buy” by Analysts - Defense World

Nov 12, 2024
pulisher
Nov 11, 2024

Tourmaline Bio, Inc. Reports Third Quarter Financial Results - TipRanks

Nov 11, 2024
pulisher
Nov 11, 2024

Tourmaline Bio (NASDAQ:TRML) Price Target Raised to $49.00 at HC Wainwright - MarketBeat

Nov 11, 2024
pulisher
Nov 07, 2024

Tourmaline Bio Inc (TRML) Quarterly 10-Q Report - Quartzy

Nov 07, 2024
pulisher
Nov 07, 2024

Tourmaline Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights - The Manila Times

Nov 07, 2024
pulisher
Nov 05, 2024

AlphaCentric Advisors LLC Sells 69,500 Shares of Tourmaline Bio, Inc. (NASDAQ:TRML) - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

Tourmaline Bio shares get buy rating on IL-6 study optimism - Investing.com Canada

Nov 05, 2024
pulisher
Nov 02, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DICE, Q - GuruFocus.com

Nov 02, 2024
pulisher
Oct 31, 2024

The Best Curling Irons, Based On Several Months Of Testing - Forbes

Oct 31, 2024
pulisher
Oct 31, 2024

Tourmaline Bio to Present at Upcoming Investor Conferences - The Manila Times

Oct 31, 2024
pulisher
Oct 29, 2024

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Short Interest Update - Defense World

Oct 29, 2024
pulisher
Oct 27, 2024

Short Interest in Tourmaline Bio, Inc. (NASDAQ:TRML) Declines By 20.0% - MarketBeat

Oct 27, 2024
pulisher
Oct 18, 2024

Cantor Fitzgerald Predicts Tourmaline Bio FY2024 Earnings - Defense World

Oct 18, 2024
pulisher
Oct 17, 2024

Tourmaline Bio, Inc. to Post FY2024 Earnings of ($2.85) Per Share, Cantor Fitzgerald Forecasts (NASDAQ:TRML) - MarketBeat

Oct 17, 2024
pulisher
Oct 16, 2024

Tourmaline Bio (NASDAQ:TRML) Shares Up 6.3%Here's What Happened - MarketBeat

Oct 16, 2024
pulisher
Oct 16, 2024

Tourmaline Bio Insiders Placed Bullish Bets Worth US$643.3k - Simply Wall St

Oct 16, 2024
pulisher
Oct 16, 2024

Keros Therapeutics appoints new Chief Medical Officer - Investing.com

Oct 16, 2024
pulisher
Oct 16, 2024

Keros Therapeutics Appoints Yung H. Chyung, M.D., as Chief Medical Officer - GlobeNewswire

Oct 16, 2024
pulisher
Oct 16, 2024

Cantor Fitzgerald Upgrades Tourmaline Bio (NASDAQ:TRML) to Strong-Buy - MarketBeat

Oct 16, 2024
pulisher
Oct 15, 2024

Tourmaline Bio (NASDAQ:TRML) Shares Gap UpStill a Buy? - MarketBeat

Oct 15, 2024
pulisher
Oct 15, 2024

Tourmaline Bio to Host Expert Webinar on Human Genetic Validation for IL-6 Inhibition in Cardiovascular Disease with Dr. Dipender Gill on Friday, November 1, 2024 - The Manila Times

Oct 15, 2024
pulisher
Oct 15, 2024

Palvella Therapeutics Announces Presentations at the 12th Pediatric Dermatology Research Alliance (PeDRA) Annual Conference - The Manila Times

Oct 15, 2024
pulisher
Oct 15, 2024

Tourmaline Bio to Host Expert Webinar on Human Genetic Validation for IL-6 Inhibition in ... - The Bakersfield Californian

Oct 15, 2024
pulisher
Oct 14, 2024

TRMLTourmaline Bio, Inc. Latest Stock News & Market Updates - StockTitan

Oct 14, 2024
pulisher
Oct 14, 2024

Investing in Tourmaline Bio Inc (TRML): What You Must Know - Knox Daily

Oct 14, 2024
pulisher
Oct 13, 2024

Tourmaline Bio: Looking To Go Beyond FcRn Inhibition With IL-6 Targeting (NASDAQ:TRML) - Seeking Alpha

Oct 13, 2024
pulisher
Oct 13, 2024

Cubist Systematic Strategies LLC Purchases Shares of 37,861 Tourmaline Bio, Inc. (NASDAQ:TRML) - MarketBeat

Oct 13, 2024
pulisher
Oct 13, 2024

Tourmaline Bio (NASDAQ:TRML) Shares Gap Down – Time to Sell? - Defense World

Oct 13, 2024
pulisher
Oct 11, 2024

Tourmaline Bio (NASDAQ:TRML) Shares Gap DownTime to Sell? - MarketBeat

Oct 11, 2024
pulisher
Oct 11, 2024

Guggenheim reiterates Buy on Tourmaline Bio shares, keeps price target By Investing.com - Investing.com UK

Oct 11, 2024
pulisher
Oct 11, 2024

Tourmaline Bio to present research at Cardiometabolic Congress By Investing.com - Investing.com South Africa

Oct 11, 2024
pulisher
Oct 11, 2024

Tourmaline Bio to present research at Cardiometabolic Congress - Investing.com

Oct 11, 2024
pulisher
Oct 11, 2024

Tourmaline Bio to Showcase Two Poster Presentations at the 2024 Cardiometabolic Health Congress - The Manila Times

Oct 11, 2024
pulisher
Oct 11, 2024

Tourmaline Bio announces CMO resignation By Investing.com - Investing.com South Africa

Oct 11, 2024
pulisher
Oct 10, 2024

Tourmaline Bio announces CMO resignation - Investing.com India

Oct 10, 2024
pulisher
Oct 10, 2024

Tourmaline Bio’s Chief Medical Officer Resigns Amicably - TipRanks

Oct 10, 2024
pulisher
Oct 10, 2024

Tourmaline Bio, Inc. Announces Resignation of Yung Chyung as Chief Medical Officer,Effective October 31, 2024 - Marketscreener.com

Oct 10, 2024
pulisher
Oct 10, 2024

Tourmaline Bio, Inc. (NASDAQ:TRML) Receives Consensus Rating of "Buy" from Analysts - MarketBeat

Oct 10, 2024
pulisher
Oct 09, 2024

Marquette Asset Management LLC Raises Stake in Vera Bradley, Inc. (NASDAQ:VRA) - Defense World

Oct 09, 2024

Tourmaline Bio Inc (TRML) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Tourmaline Bio Inc 주식 (TRML) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Kulkarni Sandeep Chidambar
CEO
Aug 16 '24
Buy
13.79
5,221
71,998
5,221
MCDADE MARK
Director
Jan 29 '24
Buy
32.50
100,000
3,250,000
448,431
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
자본화:     |  볼륨(24시간):